<?xml version="1.0" encoding="UTF-8"?>
<p>Over the 36 month follow-up period, 15.5% (N = 11) of PD patients developed PDD. These participants had significantly shorter telomeres at baseline and 18 months than those who did not develop PDD (
 <xref ref-type="fig" rid="jpd-10-jpd191724-g002">Fig. 2</xref>) but there were no significant differences for p21, p16 or inflammatory score at baseline or 18 months follow-up (data not shown).
</p>
